.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
UBS
Daiichi Sankyo
Argus Health
Moodys
Queensland Health
US Department of Justice
Deloitte
Cantor Fitzgerald

Generated: July 25, 2017

DrugPatentWatch Database Preview

Hydrocortisone butyrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for hydrocortisone butyrate and what is the scope of hydrocortisone butyrate patent protection?

Hydrocortisone butyrate
is the generic ingredient in three branded drugs marketed by Yamanouchi, Precision Dermat, Taro, Glenmark Generics, and Taro Pharm Inds, and is included in twelve NDAs. There are three patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are sixty drug master file entries for hydrocortisone butyrate. Nine suppliers are listed for this compound.

Summary for Generic Name: hydrocortisone butyrate

Tradenames:3
Patents:3
Applicants:5
NDAs:12
Drug Master File Entries: see list60
Suppliers / Packagers: see list9
Bulk Api Vendors: see list49
Clinical Trials: see list305
Patent Applications: see list3,884
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydrocortisone butyrate at DailyMed

Pharmacology for Ingredient: hydrocortisone butyrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Precision Dermat
LOCOID
hydrocortisone butyrate
CREAM;TOPICAL018514-001Mar 31, 1982AB1RXYesYes► Subscribe► Subscribe► Subscribe
Taro Pharm Inds
HYDROCORTISONE BUTYRATE
hydrocortisone butyrate
SOLUTION;TOPICAL076364-001Jan 14, 2004ATRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark Generics
HYDROCORTISONE BUTYRATE
hydrocortisone butyrate
CREAM;TOPICAL202145-001Sep 27, 2013AB2RXNoNo► Subscribe► Subscribe► Subscribe
Yamanouchi
LOCOID
hydrocortisone butyrate
OINTMENT;TOPICAL019106-001Jul 3, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Precision Dermat
LOCOID
hydrocortisone butyrate
LOTION;TOPICAL022076-001May 18, 2007RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: hydrocortisone butyrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Precision Dermat
LOCOID LIPOCREAM
hydrocortisone butyrate
CREAM;TOPICAL020769-001Sep 8, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: hydrocortisone butyrate

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,389,502Stabilized steroid composition and method for its preparation► Subscribe
8,546,364Stabilized steroid composition and method for its preparation► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Chubb
Fuji
Baxter
Moodys
Daiichi Sankyo
Chinese Patent Office
US Department of Justice
Cipla
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot